[BIO-B] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[BIO-B] Bio-Rad Laboratories, Inc.
Announcement Date
17-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 607.51%
YoY- 152.97%
Quarter Report
BIO-B's Result
BIO-B's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 632,124 681,110 676,844 730,288 680,800 691,099 700,062 -6.57%
PBT 137,102 -1,500,427 84,829 1,091,282 -209,168 -1,222,880 -4,371,017 -
Tax 30,845 -338,176 15,867 263,548 -44,936 -295,696 -1,001,404 -
NP 106,257 -1,162,251 68,962 833,494 -164,232 -927,184 -3,369,613 -
Tax Rate -22.50% - -18.70% -24.15% - - - -
Total Cost 525,867 1,843,361 607,882 -103,206 845,032 1,618,283 4,069,675 -74.40%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 16.81 -170.64 10.19 114.13 -24.12 -134.16 -481.33 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS 3.65 -39.59 2.33 27.89 -5.53 -31.12 -112.58 -
EPS Diluted 3.64 -39.59 2.32 27.78 -5.52 -31.12 -112.57 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.